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Abstract: Hemoglobin (Hb) concentration and oxygen saturation levels are 
important  biomarkers  for  various  diseases,  including  cancer.  Here,  we 
investigate  the  ability  to  measure  these  parameters  for  tissue  using 
spectroscopic optical coherence tomography (SOCT). A parallel frequency 
domain OCT system is used with detection spanning the visible region of 
the  spectrum  (450  nm  to  700  nm).  Oxygenated  and  deoxygenated  Hb 
absorbing phantoms are analyzed. The results show that Hb concentrations 
as low as 1.2 g/L at 1 mm can be retrieved indicating that both normal and 
cancerous tissue measurements may be obtained. However, measurement of 
oxygen saturation levels may not be achieved with this approach. 
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1. Introduction 
Multiple  disorders  affect  tissue  blood  content  and  oxygen  levels,  including  infectious 
processes,  polyps,  and  cancer  [1];  hence,  knowledge  of  these  parameters  can  be  very 
instrumental in diagnosing diseases. To obtain this information, optical techniques can take 
advantage of the very distinct absorption features of oxygenated (oxy-) and deoxygenated 
(deoxy-) hemoglobin (Hb), and have the ability to provide noninvasive, in-vivo monitoring. 
However, current optical techniques for this purpose, including pulse oximetry, elastic light 
spectroscopy  [2],  diffuse  reflectance  spectroscopy  [3],  and  differential  path  length 
spectroscopy [4], suffer from poor spatial resolution, thus only obtaining tissue properties 
averaged over large volumes. These methods are also unable to obtain precise information 
regarding  the  trajectories  of  the  measured  photons;  as  a  result,  parameters  of  interest, 
including absorption, are estimated by employing empirical and/or Monte Carlo simulations 
rather than physical models. These shortcomings have motivated the development of other 
methods that may improve diagnostic efficacy by providing better spatial information and 
insight to tissue properties by means of physical models. One such method is spectroscopic 
optical coherence tomography (SOCT). 
Optical coherence tomography (OCT) is an imaging modality based on low-coherence 
interferometry  (LCI)  that  provides  noninvasive,  high  resolution,  cross-sectional  images  of 
biological  samples  [5].  Advances  in  OCT  have  allowed  for  acquisition  of  depth-resolved 
functional  information  using  SOCT  [6–8],  introducing  the  possibility  to  improve  current 
clinical methods for quantifying tissue properties in vivo [9,10]. Compared to the other optical 
techniques  mentioned  above,  SOCT  provides  spectroscopic  information  with  high  spatial 
resolution allowing for functional information to be directly overlaid with images of tissue 
structure. Additionally, SOCT measures singly scattered light, thereby allowing the use of 
more simple physical models, such as Beer’s law. 
To obtain depth resolved spectroscopic information, SOCT typically employs short-time 
Fourier Transforms (STFT) or continuous wavelet transforms (CWT). Unfortunately, these 
operations suffer from an inherent trade-off between spatial and spectral resolution that has 
limited the ability to quantitatively process depth resolved spectra. To ameliorate this trade 
off, the dual-window (DW) method for processing SOCT signals was developed. The DW 
method  is  simply  the  product  of  two  STFT’s  with  different  window  sizes,  which,  if 
judiciously chosen, can be used to independently tune the spatial and spectral resolution [11]. 
We have demonstrated the use of the DW for SOCT, in combination with Fourier domain LCI 
(fLCI)  and  light  scattering  spectroscopy  (LSS),  to  probe  morphological  features  in  tissue 
phantoms [8], and for obtaining cell nuclear size to diagnose malignant states in ex-vivo tissue 
samples [12]. 
In  this  paper,  we  demonstrate  the  ability  to  quantitatively  measure  depth  resolved 
absorption spectra to extract a wide range of absorber concentrations using oxy- and deoxy- 
Hb phantoms. Further, we investigate the lower limit of Hb concentration and percent oxygen 
saturation that can be obtained using our system to determine the feasibility of characterizing 
Hb absorption in tissue. 
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2.1 System design 
A parallel frequency domain OCT system (pfdOCT) is used, which consists of a Michelson 
interferometer geometry for coherence gating, with the addition of 4 lenses that form a 4-F 
imaging system for parallel detection [13]. A series of spectral filters are used to shape the 
light  emitting  from  a  super  continuum  light  source  (Fianium,  Eugene,  OR)  that  is  then 
collimated onto the sample and reference mirror using L2 and L3/L4 as illustrated in Fig. 1. 
Then,  using  lenses  L3/L4  and  L5,  the  scattered  and  reflected  light  from  the  sample  and 
reference mirror, respectively, is imaged on to the entrance slit of an imaging spectrograph 
(Princeton  Instruments,  Trenton  NJ).  This  configuration  allows  simultaneous  (or  parallel) 
detection of multiple interferograms. 
 
Fig. 1. Parallel frequency domain OCT system and sample. L ≈400 µm is the thickness of the 
Hb absorbing phantom. 
2.2 Sample preparation and detection 
Oxy- and deoxy- Hb samples were prepared at varying concentrations ranging from ~5 g/L to 
70  g/L  (~78  µM  to  1085  µM).  For  the  oxy-Hb  samples,  human  ferrous  stable  Hb  in 
lyophilized powder form (Sigma-Aldrich, St. Louis, MO) was diluted in purified water until 
the desired concentration was achieved. To produce deoxy-Hb, a trace amount of sodium 
dithionite,  which removes the oxygen in oxy-Hb, was introduced to a solution of the Hb 
powder and phosphate buffered saline (PBS). The use of PBS here is to assure that reactions 
that  degrade  specific  absorption  do  not  occur  [14].  The  samples  were  then  placed  in  a 
container composed of two glass slides separated by spacers of thickness L ≈400 µm, as seen 
in the inset of Fig. 1. 
For detection, the grating in the system’s imaging spectrograph is set to operate in the 
visible region of the spectrum, centered about 575 nm with a bandwidth of ~250 nm. As seen 
in Fig. 2(a), this spectral range corresponds to a region of significant Hb attenuation, thus 
leading to higher sensitivity for detecting absorption compared to other OCT systems that 
operate at near infrared wavelengths [5]. From Fig. 2(b), one can also observe that, in this 
range, the absorption coefficients of oxy- and deoxy- Hb are significantly different, thereby 
allowing Hb oxygenation saturation states to be measured. A more thorough discussion is 
included in section 3.3. 
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Fig. 2. Molar extinction coefficients of oxy-/deoxy- Hb over a large spectral range (a), and 
across the visible region of the spectrum (b). The dotted black lines in (b) delineate the region 
where the oxy- and deoxy- Hb coefficients exhibit the greatest dissimilarity (correlation R~0). 
Data compiled by Prahl [15]. 
3. Results 
3.1 Absorption profiles 
The data were acquired from the Hb samples using the pfdOCT system. The signal from a 
single lateral channel (A-scan) may de described by, 
  ( ) 2 cos 2 , r s s r I I I I I k OPL = + + ⋅   ɶ    (1) 
where Ir is the reference field intensity, Is is the sample field intensity,  OPL is the optical 
path length difference between the sample and reference arms, and k is the wavenumber (k = 
2π/λ). The non-interferometric terms in the signal (Ir + Is) were eliminated using subtraction 
of separate background acquisitions, and the source’s spectral dependence was removed by 
normalizing by the reference field. The resulting interferogram was processed using the DW 
method with Gaussian window sizes w1 = 0.061 µm
−1 and w2 = 0.907 µm
−1 to yield depth-
resolved spectroscopic information with spatial resolution of 3.05 µm and spectral resolution 
of 3.20 nm. The experimental spatial resolution of the pfdOCT system is ~1.10 µm. 
The spectrum from the front of the rear cover glass of the sample, corresponding to an 
absorber  thickness  of  400µm,  was  recorded  (see  inset  of  Fig.  1).  Since  the  light  only 
experiences attenuation, the intensity of the processed depth resolved spectrum is described 
by Beer’s law, 
  ( ) 0 ( , ) exp ( ) . a I L rI L λ λ = −     (2) 
where µa(λ) is the wavelength- and concentration-dependent attenuation coefficient, r is the 
reflectivity (or scattering cross section) of the sample, and L is the physical thickness of the 
absorber. The initial light intensity, I0, is measured from the same surface in absence of oxy-
/deoxy- Hb, using water or PBS as the sample. Furthermore, note that the intensity depends 
on L and not 2L resulting from the square root term in Eq. (1). Figures 3(a) and 3(b) illustrate 
representative experimental normalized oxy- and deoxy- Hb intensity profile, respectively, 
obtained  after  processing.  The  theoretical  absorption  curves  (dotted  black  lines)  are  also 
plotted. Figures 3(c) and 3(d) are the corresponding attenuation coefficients. Note that the 
ideal and the measured profiles are in excellent agreement, where the absorption peaks at 540 
nm and 575 nm for oxy-Hb, and at 555 nm for deoxy-Hb are clearly evident. 
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Fig. 3. Oxy-Hb (a) and deoxy-Hb (b) normalized absorption spectra, with Hb concentrations of 
50 g/L and 68 g/L, respectively. The solid lines are experimentally measured, and the dotted 
black lines are the ideal. Oxy-Hb (c) and deoxy-Hb (d) measured and theoretical attenuation 
coefficients. 
3.2 Hemoglobin concentrations 
To calculate the Hb concentration (CHb), the absorption coefficient may be expressed in terms 
of the extinction coefficient, ε(λ), which is independent of CHb: µa(λ) = CHb· ε(λ). Here, all 
constants have been included in ε, where the Hb molecular weight used is MW = 64500 
g/mole. Thus, by taking the natural log of Eq. (2), and substituting for µa(λ), we obtain, 
 
0
( , )
ln ( ) ln( ). Hb
I L
C L r
I
λ
ε λ
 
− = −  
 
   (3) 
Note that ε(λ) values for oxy-/deoxy- Hb are tabulated and are readily available (Fig. 1 
[15], ). 
For each of the prepared samples, we analyze the absorption profiles of 25 distinct spatial 
locations, where the spectra are processed as described in section 3.1. Then, using Eq. (3), and 
known thickness L (which may be obtained from imaging), we calculate the concentration by 
fitting the data to a line of the form y = mx + b, using a linear least squares method. Here, x is 
ether  the  oxy-  or  deoxy-  Hb  extinction  coefficient  and  the  computed  m  =    CHbL.  This 
procedure was repeated for 6 different concentrations. The results are summarized in Fig. 4. 
We find that the measured and expected concentration values are in excellent agreement, 
with R
2
oxy = 0.9957 and R
2
deoxy = 0.9600. The average standard deviation for all measurements 
is 3.10 g/L (no statistical significance was observed between the oxy- and deoxy- Hb values, 
p-val = 0.82). This value represents the lower limit of Hb concentration that may be detected 
at this depth. A more heuristic parameter, however, is obtained by multiplying the minimum 
measurable concentration by the depth, which gives a depth-independent value—this gives 
CHb-min = 1.2 g/L at 1 mm (herein noted as g/L-mm). It is worth highlighting here that the total 
Hb concentration in normal tissue has been reported to be ~1.8 g/L, and as much as 3.2 times 
higher for cancerous tissue [3]. 
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Fig. 4. Measured hemoglobin concentration for oxy- (a) and deoxy- (b) Hb samples. Error bars 
represent a standard deviation from the mean of 25 measurements. 
3.3 Oxygen saturation 
In biological samples, absorption will also depend on the oxygen saturation state of Hb. Thus, 
a more accurate model of the expected signal in biological samples is given by Eq. (4), 
  ( ) 2 2 0 ( , ) exp ( ) ( ) HbO HbO Hb Hb I L rI L C C λ ε λ ε λ   = − +      (4) 
where εHbO2, εHb, CHbO2 and CHb are the extinction coefficients and concentrations for oxy-
/deoxy- Hb, respectively. This, in turn, can be written as an overdetermined set of linear 
equations to solve for CHbO2 and CHb, 
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   (5) 
where λi for 1≤ i ≤ n are the discretely measured wavelengths within the operating region. 
Finally, partial oxygen saturation (SO2) can be calculated by Eq. (6), 
 
2
2
2
.
HbO
O
HbO Hb
C
S
C C
=
+
   (6) 
Based on this analysis, it is clear that the ability to correctly measured oxygen saturation 
depends on the extent to which the method, given by Eq. (5), can correlate the measured data 
to the correct chromophore species, i.e., oxy- or deoxy- Hb. For example, if y is the measured 
data and x is the model in question, the correlation of y = x, using a linear least squares fit, 
determines  how  well  the  model  fits  the  data.  For  this  example,  a  high  correlation  value 
signifies that the model describes the observations well; more importantly, for our study, high 
correlation values indicate that the method will clearly distinguish between the contributions 
to attenuation from the oxy- species and the deoxy- species. Therefore, a high correlation 
value suggests that oxygen saturation levels can be measured correctly. 
To determine the lowest concentration at which oxygen saturation states may be correctly 
measured, the correlation coefficient of the linear regression used to determine concentration 
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nm to 585 nm was used, which was chosen to highlight the disparity between εHbO2 and εHb. 
The correlation coefficient between the theoretical εHbO2 and εHb in this region, delineated by 
the dotted black lines in Fig. 1(b), is ~0. The results are summarized below, where Fig. 5(a) 
shows  the  correlations  of  the  oxy-Hb  data  when  compared  to  the  oxy-  and  deoxy-  Hb 
extinction coefficients, and Fig. 5(b) shows the results for the deoxy-Hb data. 
 
Fig. 5. (a) Correlation coefficients between the oxy-Hb data and the oxy-/deoxy- Hb extinction 
coefficients at varying concentrations. (b) Correlation coefficients between the deoxy-Hb data 
and the oxy-/deoxy- Hb extinction coefficients at varying concentrations. 
Good agreement (R>0.65) is observed for concentration values higher than 10 g/L if the 
data are compared to the correct corresponding species (i.e., oxy-Hb data to oxy-Hb model, 
etc.); further, there exist a sharp cut off below this point. In contrast, a low correlation value 
(R<0.2) is observed for all concentrations above 10 g/L if the data are compared to the wrong 
model. This suggests that, while concentration values may be determined as low as 1.2 g/L-
mm, oxygenation states can only be accurately determined for concentrations above 4 g/L-
mm ( = 10 g/L × 0.4 mm). 
4. Discussion 
In this paper, we have shown the ability to measure Hb concentrations as low as 1.2 g/L-mm, 
and over a wide range, with very good agreement with the expected values (R
2 > 0.9). As 
stated in section 3.2, normal (colorectal) tissue Hb concentrations have been reported to be 
~1.8 g/L [3]: this indicates that normal Hb concentrations are well within the range of SOCT 
detection at depths greater than ~0.67 mm ( = 1.2 g/L-mm   1.8 g/L). Furthermore, abnormal 
(or cancerous) concentration values have been observed to be ~3.2 times greater than normal 
(~5.7 g/L) [3], hence these are also detectable using our methods. 
We have also determined that oxygen saturation states may only be correctly measured at 
concentrations higher than 4 g/L-mm. These values fall outside the range of detection for 
normal tissue, where penetration depths would need to be greater than L = 2 mm. However, 
for cancerous tissue, the expected concentration values are within feasible detection range 
(L<1 mm). Further, the expected concentration of Hb within blood (150g/L) would allow 
oxygen saturation to also be detected with this method. 
It  is  worthwhile  to  compare  these  results  with  previous  works  aimed  at  extracting 
absorption properties from Hb samples using SOCT: First, Faber et al. showed the feasibility 
of extracting Hb absorption coefficients [9] and later oxygenation saturation states [16] in 
blood, where concentrations are typically 150 g/L. Detection for those studies was centered 
about the isobestic point around 800 nm. Later, it was reported that, due to the contributions 
of scattering, absolute chromophore quantification was not feasible [17]. These conclusions 
result,  in  part,  from  the  choice  of  wavelength  range,  which  shows  relatively  weak  Hb 
absorption  around  800  nm.  Additionally,  methods  have  been  presented  that  separate 
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absorber concentration within tissues. 
Recently, Bosschaart et al. used a similar system as the one presented here (including 
spectral detection range), named low-coherence spectroscopy (LCS) to assess absorption [10]. 
Using scattering polystyrene spheres and a green dye for absorption, it was found that LCS 
was a promising technique for in-vivo determination of tissue absorption properties regardless 
of scattering. This further supports the claim that the approach used here can be applied to 
tissue, despite the fact that the samples did not contain scatterers. Like the work presented in 
[10],  the  technique  presented  here  offers  higher  sensitivity  by  operating  in  the  visible 
wavelength region. However, the methods for detecting absorption differ: In this study, the 
DW method is used, which enables high spectral resolution along with the same spatially 
resolved imaging capabilities as OCT. In [10], the method requires translation of both the 
sample and reference arms, and must also sacrifice spatial resolution to achieve the spectral 
resolution required for quantification. 
In summary, we have shown that our pfdOCT system using the DW method is capable of 
measuring hemoglobin concentrations as low as those found in healthy and cancerous tissue. 
This further supports the hypothesis that SOCT may improve upon current optical techniques 
that  are  used  to  assess  tissue  properties  for  disease  diagnosis.  Future  works  will  aim  to 
implement this technique to assess Hb concentration within tissue. 
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